title: Major bleeding and severe thrombocytopenia after combined heparin and abciximab-c7E3 Fab therapy.
authors.affiliation: Department of Vascular Surgery, University Hospital Herne, Ruhr-University Bochum, 44625-Herne, Germany.
authors.forename: L G Y
authors.initials: LG
authors.lastname: Claeys
authors.forename: W
authors.initials: W
authors.lastname: Berg
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005263:Femoral Artery / Q000293:injuries*; D006401:Hematologic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000150:complications; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007431:Intraoperative Complications / Q000628:therapy*; D007511:Ischemia / Q000601:surgery; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D006401:Hematologic Agents; D007140:Immunoglobulin Fab Fragments; D006493:Heparin; D000077284:Abciximab